Expression and function of CD95 (FAS/APO-1) in leukaemia-lymphoma tumour lines

British Journal of Haematology

Volumn 96, Issue 3, 1997, Pages 584-593

  Dirks, Wilhelm ^a   Schöne, Stefanie ^a   Uphoff, Cord ^a   Quentmeier, Hilmar ^a   Pradella, Silke ^a   Drexler, Hans G ^a  

^a LEIBNIZ INSTITUTE DSMZ GERMAN COLLECTION OF MICROORGANISMS AND CELL CULTURES   (Germany)

Author keywords

Apoptosis; CD95 (FAS APO 1) expression; Cell death resistance; Haemopoietic cell lines; Programmed cell death

Indexed keywords

FAS ANTIGEN;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHOMA; PRIORITY JOURNAL;

ANTIGENS, CD95; APOPTOSIS; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA; LYMPHOMA; PROTEIN BIOSYNTHESIS; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0031037778     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.d01-2048.x     Document Type: Article

References (38)

1. Aggarwal, B.B., Singh, S., LaPushin, R. & Totpal, K. (1995) Fas antigen signals proliferation of normal human diploid fibroblasts and its mechanism is different from tumor necrosis factor receptor. FEBS Letters, 364, 5-8.
2. Baker, S. & Reddy, E.P. (1996) Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene, 12, 1-9.
3. Boldin, M.P., Varfolomeev, E.E., Pancer, Z., Mett, I.L., Camonis, J.H. & Wallach, D. (1995) A novel protein that interacts with the death domain of Fas/Apo-1 contains a sequence motif related to the death domain. Journal of Biological Chemistry, 270, 7795-7798.
4. Cascino, I., Fuicci, G., Papoff, G. & Ruberti, G. (1995) Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. Journal of Immunology, 154, 2706-2713.
5. Cheng, J., Zhou, T., Liu, C., Shapiro, M., Brauer, L.. Kiefer, M.C., Barr, P.J. & Mountz, J.D. (1994) Protection from FAS-mediated apoptosis by a soluble form of the FAS molecule. Science, 265, 1759-1762.
6. Chinnaiyan, A.M., O'Rourke, K., Tewari, M. & Dixit, V.M. (1995) FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis, Cell. 81, 505-512.
7. Cohen, J.J. & Duke, R.C. (1992) Apoptosis and programmed cell death in immunity. Annual Reviews of Immunology, 10, 267-293.
8. Debatin, K.-M. & Krammer, P.H. (1995) Resistance to Apo-1 (CD95)-induced apoptosis in T-ALL is determined by a BCL-2 independent anti-apoptotic program. Leukemia, 9, 815-812.
9. Dirks, W., Nolte, M., Werner, M., Koch, C. & Drexler, H.G. (1996) Preservation of functional and regulatory domains of expressed bcl-2 genes in non-Hodgkin's lymphoma. Leukemia, 10, 150-158.
10. Drexler, H.G., Dirks, W., MacLeod, R.A.F., Quentmeier, H. & Steube, K. (1995) DSM Catalogue of Human and Animal Cell Cultures, 5th edn. Braunschweig.
11. Enari, M., Hase, A. & Nagata, S. (1995) Apoptosis by a cytosolic extract from Fas-activated cells, EMBO Journal, 14, 5201-5214.
12. Fisher, G.H., Rosenberg, F.J., Straus, S.E., Dale, J.K., Middleton, J.K., Lin, A.Y., Strober, W., Lenardo, M. & Puck, J.M. (1995) Dominant interfering Fas mutations impair apoptosis in a human autoimmune lymphoproliferative disease. Cell, 81, 935-946.
13. Hashimoto, S., Ishii, A. & Yonehara, S. (1991) The Elb oncogene of adenovirus confers cellular resistance to cytotoxicity to TNF and treatment with anti-Fas antibody. International Immunology, 3, 343-351.
14. Hsu, H., Xiong, J. & Goeddel, D.V. (1995) The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell, 81, 495-504.
15. Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S., Sameshima, M., Hase, A., Seto, Y. & Nagata, S. (1991) The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell, 66, 233-243.
16. Izui, S., Kelley, V.E., Masuda, K., Yoshida, H., Roths, J.B. & Murphy, E.D. (1984) Induction of various autoantibodies by mutant gene lpr in several strains of mice. Journal of Immunology, 133, 227-233.
17. Knipping, E., Debatin, K.-M., Stricker, K., Heilig, B., Eder, A. & Krammer, P.H. (1995) Identification of a soluble Apo-1 in supernatants of human B- and T-cell lines and increased serum levels in B and T cell leukemias. Blood, 85, 1662-1569.
18. Kuchino, Y. & Müller, W.E.G. (1996) Apoptasis, Springer, Berlin.
19. Mappara, M.Y., Bargou, R., Zugck, C., Dohner, H., Ustaoglu, F., Krammer, P.H. & Dörken, B. (1993) APO-1-mediated apoptosis or proliferation in human B lymphocytic leukaemia: correlation with bcl-2 oncogene expression. European Journal of Immunology, 23, 702-708.
20. Nguyen, P.L., Harris, N.L., Ritz, J. & Robertson, M.J. (1996) Expression of CD9S antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease. American Journal of Pathology, 148, 847-853.
21. Nishiuchi, R., Yoshino, T., Matsuo, Y., Sakuma, I., Cao, L., Seine, Y., Takhashi, K. & Akagi, T. (1996) The FAS antigen is detected on immature B cells and the representative cell lines show FAS-mediated apoptosis. British Journal of Haematology, 92, 302-307.
22. Oehm, A., Behrmann, I., Falk, W., Pawlita, M., Maier, G., Klas, C., Weber, L., Richards, S., Dhein, J., Trauth, B.C., Debatin, K.-M. & Krammer, P.H. (1992) Molecular cloning and expression of the APO-1 cell surface antigen, a new member of the TNF receptor superfamily. Journal of Biological Chemistry, 267, 10709-10715.
23. Owen-Schaub, L.B., Radinsky, R., Kruzel, E., Berry, K. & Yonehara, S. (1994) Anti-Fas on non-hematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness. Cancer Research, 54, 1580-1586.
24. Pisa, P., Halapi, E., Pisa, E.K., Gerdin, E., Hising, C., Bucht, A., Gerdin, B. & Kiessling, R. (1992) Selective expression of interleukin-10, interferon-gamma and GMCSF in ovarian cancer biopsies. Proceedings of the National Academy of Sciences of the United States of America, 89, 7708-7712.
25. Rieux-Laucat, F., Le Deist, F., Hivroz, J.P., Roberts, I.A.G., Debatin, K.-M., Fischer, A. & De Villarty, J.P. (1995) Muatations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science, 268, 1347-1350.
26. Russel, J.H., Rush, B., Weaver, C. & Wang, R.(1993) Mature T-cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. Proceedings of the National Academy of Sciences of the united States of America, 90, 4409-4416.
27. Sambrook, J., Fritsch, E.F. & Maniatis, T. (1993) Molecular Cloning: a Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press, New York.
28. Sato, T., Irie, S., Kitada, S. & Reed, J.C. (1995) FAP-1: a protein tyrosine phosphatase that associates with Fas. Science, 268, 411-415.
29. Shima, Y., Nishimoto, N., Ogata, A., Fujii, Y., Kazuyuki, Y. & Kishimoto, T. (1995) Myeloma cells express FAS antigen (APO-1/ CD95) but only some are sensitive to anti-FAS antibody in apoptosis. Blood, 85, 757-764.
30. Sobel, E.S., Kakkanaiah, V.N., Cohen, P.L. & Eisenberg, R.A. (1993) Correction of gld autoimmunity by co-fusion of normal bone marrow suggest that gld is a mutation of the fas ligand gene. International Journal of Immunology, 5, 1275-1281.
31. Stanger, B.Z., Leder, P., Lee, T.H., Kim, E. & Seed. B. (1995) RIP: a novel protein containing a death domain that interacts with Fas/ Apo-1 (CD95) in yeast and causes cell death. Cell, 81, 513-523.
32. Tartaglia, L., Ayres, L., Wong, G.H.W. & Goeddel, D.V. (1992) A novel domain within the 55kDa TNF receptor signals cell death. Cell, 74, 845-855.
33. Trauth, B.C., Klas, C., Peters, A.M., Matzku, S., Möller, P., Falk, W., Debatin, K.-M. & Krammer, P.H. (1989) Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science, 245, 301-305.
34. + lymphocytes in EBV-induced infectious mononucleosis. Blood, 80, 452-460.
35. Watson, M.L., Rao, J.K., Gilkeson, G.S., Ruiz, P., Eicher, E.M., Pisetzky, D.S., Matsuzawa, A., Rochelle, J.M. & Seldin, M.F. (1992) Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. Journal of Experimental Medicine, 176, 1645-1654.
36. Westendorp, J., Lammert, J.M. & Jelinek, D.F. (1995) Expression and function of FAS (APO-1, CD95) in patient myeloma cells and myeloma cell lines. Blood, 85, 3566-3576.
37. Xerri, L., Carbuccia, N., Parc, P., Hassoun, J. & Birg, F. (1995) Frequent expression of FAS/APO-1 in Hodgkin's disease and anaplastic large cell lymphomas. Histopathology, 27, 235-241.
38. Yonehara, S., Ishii, A. & Yonehara, M. (1989) A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen codownregulated with the receptor of tumor necrosis factor. Journal of Experimental Medicine, 169, 1747-1756.